AF
MRNA icon

Arrow Financial’s Moderna MRNA Stock Holding History

Arrow Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-250
Closed -$25.8K – 358
2023
Q3 		$25.8K Buy
250
+200
+400% +$22.3K ﹤0.01% 247
2023
Q2 		$6.08K Hold
50
– – ﹤0.01% 284
2023
Q1 		$7.68K Hold
50
– – ﹤0.01% 283
2022
Q4 		$9K Sell
50
-200
-80% -$32.7K ﹤0.01% 285
2022
Q3 		$30K Hold
250
– – ﹤0.01% 236
2022
Q2 		$36K Hold
250
– – ﹤0.01% 227
2022
Q1 		$43K Hold
250
– – 0.01% 226
2021
Q4 		$63K Hold
250
– – 0.01% 200
2021
Q3 		$96K Buy
250
+200
+400% +$73.8K 0.01% 184
2021
Q2 		$12K Hold
50
– – ﹤0.01% 282
2021
Q1 		$7K Hold
50
– – ﹤0.01% 293
2020
Q4 		$5K Buy
+50
New +$5.06K ﹤0.01% 291

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrow Financial's MRNA Position: Q4 2023 in Review

Arrow Financial sold out of Moderna (MRNA) in Q4 2023, closing a stake of 250 shares — an estimated $25.8K sold.

Arrow Financial first reported a position in MRNA in Q4 2020 and held it in 12 quarters. The position peaked at $96K in Q3 2021. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Arrow Financial reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Arrow Financial sold 250 Moderna shares in Q4 2023, an estimated $25.8K.
  • Arrow Financial first reported a position in Moderna in Q4 2020 and held it in 12 quarters.
  • Arrow Financial's Moderna position peaked at $96K in Q3 2021.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Arrow Financial's 13F filing for Q4 2023, filed 12 Feb 2024.